These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Local treatments using antiviral and non-antiviral drugs for herpes facialis and genitalis (excluding pregnant females and neonates at risk)]. Chosidow O; Lebrun-Vignes B Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):635-45. PubMed ID: 12122334 [No Abstract] [Full Text] [Related]
5. Acyclovir and other chemotherapy for herpes group viral infections. Balfour HH Annu Rev Med; 1984; 35():279-91. PubMed ID: 6326661 [TBL] [Abstract][Full Text] [Related]
6. Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialis. Spruance SL; Crumpacker CS; Haines H; Bader C; Mehr K; MacCalman J; Schnipper LE; Klauber MR; Overall JC N Engl J Med; 1979 May; 300(21):1180-4. PubMed ID: 86158 [TBL] [Abstract][Full Text] [Related]
11. [Value of the biochemical pattern of demyelinization in the cerebrospinal fluid in the diagnosis of multiple sclerosis]. Matías-Guiu J; Martínez-Vázquez JM; Ruibal A; Codina-Puiggrós A Med Clin (Barc); 1986 Nov; 87(14):582-4. PubMed ID: 3784678 [No Abstract] [Full Text] [Related]
13. The treatment of herpetic infections: state of the art. Terezhalmy GT Quintessence Int Dent Dig; 1981 Feb; 12(2):133-8. PubMed ID: 6169108 [No Abstract] [Full Text] [Related]
14. The natural history of recurrent oral-facial herpes simplex virus infection. Spruance SL Semin Dermatol; 1992 Sep; 11(3):200-6. PubMed ID: 1390034 [TBL] [Abstract][Full Text] [Related]
15. [Acyclovir for prevention of recurrent Herpes labialis?]. Färber I Med Monatsschr Pharm; 2008 Jun; 31(6):226. PubMed ID: 18661914 [No Abstract] [Full Text] [Related]
16. Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis. Selmaj K; Jurewicz A; Matysiak M; Raine CS Neurology; 2009 May; 72(19):1708; author reply 1708-9. PubMed ID: 19433749 [No Abstract] [Full Text] [Related]
17. An update on short-course intermittent and prevention therapies for herpes labialis. Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887 [TBL] [Abstract][Full Text] [Related]
18. Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation. Iino T; Gondo H; Ohno Y; Minagawa H; Iwasaki H; Maruyama T; Nakashima H; Niho Y Bone Marrow Transplant; 1996 Dec; 18(6):1185-8. PubMed ID: 8971394 [TBL] [Abstract][Full Text] [Related]